지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population
Gut and Liver
2024 .03
Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Clinical and Molecular Hepatology
2024 .04
Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
Clinical and Molecular Hepatology
2024 .04
A New Korean Nomenclature for Steatotic Liver Disease
Gut and Liver
2024 .09
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
Diverse Functions of Macrophages in Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Inflammation and Metabolism
Immune Network
2025 .02
In response to: Steatotic liver disease-know your enemies
Clinical and Molecular Hepatology
2024 .04
Steatotic liver disease: Know your enemies
Clinical and Molecular Hepatology
2024 .04
The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective
Clinical and Molecular Hepatology
2024 .04
Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
Gut and Liver
2022 .07
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
Clinical and Molecular Hepatology
2024 .07
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
WFDC2 exacerbates metabolic dysfunction associated steatotic liver disease
한국실험동물학회 학술발표대회 논문집
2025 .02
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology
2023 .04
Immunopathogenesis of liver fibrosis in steatotic liver disease
Clinical and Molecular Hepatology
2024 .04
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
Gut and Liver
2021 .01
Liver transplantation for acute on chronic liver disease; when and how?
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Comparative Outcomes of Pediatric Liver Transplantation for Metabolic Liver Diseases and Biliary Atresia
대한외과학회 학술대회 초록집
2017 .11
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study
Clinical and Molecular Hepatology
2024 .04
0